strontium chloride Sr 89

RADIATION4 trials

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC, M.D. Anderson Cancer Center, University Hospital Birmingham

Conditions

Metastatic CancerProstate Cancer

Phase 2

Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases

TerminatedNCT00080782

M.D. Anderson Cancer CenterMetastatic Cancer, Prostate Cancer

Start: 2002-02-28End: 2005-01-31Updated: 2018-10-31

Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy

CompletedNCT00554918

University Hospital BirminghamMetastatic Cancer, Prostate Cancer

Start: 2005-02-28End: 2013-06-30Target: 300Updated: 2013-08-07

Phase 3

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

TerminatedNCT00024167

M.D. Anderson Cancer CenterProstate Cancer

Start: 2002-04-30Updated: 2016-03-22

Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases

CompletedNCT00002503

European Organisation for Research and Treatment of Cancer - EORTCMetastatic Cancer, Prostate Cancer

Start: 1992-10-31Updated: 2012-09-24